GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Awakn Life Sciences Corp (OTCPK:AWKNF) » Definitions » ROA %

Awakn Life Sciences (Awakn Life Sciences) ROA %

: -256.17% (As of Oct. 2023)
View and export this data going back to 2021. Start your Free Trial

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Awakn Life Sciences's annualized Net Income for the quarter that ended in Oct. 2023 was $-1.89 Mil. Awakn Life Sciences's average Total Assets over the quarter that ended in Oct. 2023 was $0.74 Mil. Therefore, Awakn Life Sciences's annualized ROA % for the quarter that ended in Oct. 2023 was -256.17%.

The historical rank and industry rank for Awakn Life Sciences's ROA % or its related term are showing as below:

AWKNF' s ROA % Range Over the Past 10 Years
Min: -231.91   Med: -197.08   Max: -162.25
Current: -199.75

During the past 2 years, Awakn Life Sciences's highest ROA % was -162.25%. The lowest was -231.91%. And the median was -197.08%.

AWKNF's ROA % is ranked worse than
93.32% of 1557 companies
in the Biotechnology industry
Industry Median: -35.71 vs AWKNF: -199.75

Awakn Life Sciences ROA % Historical Data

The historical data trend for Awakn Life Sciences's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Awakn Life Sciences Annual Data
Trend Jan22 Jan23
ROA %
-231.88 -156.20

Awakn Life Sciences Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
ROA % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -104.97 -210.79 -143.37 -266.53 -256.17

Competitive Comparison

For the Biotechnology subindustry, Awakn Life Sciences's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Awakn Life Sciences ROA % Distribution

For the Biotechnology industry and Healthcare sector, Awakn Life Sciences's ROA % distribution charts can be found below:

* The bar in red indicates where Awakn Life Sciences's ROA % falls into.



Awakn Life Sciences ROA % Calculation

Awakn Life Sciences's annualized ROA % for the fiscal year that ended in Jan. 2023 is calculated as:

ROA %=Net Income (A: Jan. 2023 )/( (Total Assets (A: Jan. 2022 )+Total Assets (A: Jan. 2023 ))/ count )
=-6.812/( (5.448+3.274)/ 2 )
=-6.812/4.361
=-156.20 %

Awakn Life Sciences's annualized ROA % for the quarter that ended in Oct. 2023 is calculated as:

ROA %=Net Income (Q: Oct. 2023 )/( (Total Assets (Q: Jul. 2023 )+Total Assets (Q: Oct. 2023 ))/ count )
=-1.888/( (0.678+0.796)/ 2 )
=-1.888/0.737
=-256.17 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Oct. 2023) net income data. ROA % is displayed in the 30-year financial page.


Awakn Life Sciences  (OTCPK:AWKNF) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Oct. 2023 )
=Net Income/Total Assets
=-1.888/0.737
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-1.888 / 0.084)*(0.084 / 0.737)
=Net Margin %*Asset Turnover
=-2247.62 %*0.114
=-256.17 %

Note: The Net Income data used here is four times the quarterly (Oct. 2023) net income data. The Revenue data used here is four times the quarterly (Oct. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


Awakn Life Sciences ROA % Related Terms

Thank you for viewing the detailed overview of Awakn Life Sciences's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


Awakn Life Sciences (Awakn Life Sciences) Business Description

Traded in Other Exchanges
Address
301?217 Queen Street West, Toronto, ON, CAN, M5V 0R2
Awakn Life Sciences Corp is a clinical-stage biotechnology company intended to develop therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder. The Company focuses on Alcohol Use Disorder (AUD), a condition affecting the people in the US and key international markets and many people globally for which the current standard of care is inadequate, enabling to provide breakthrough therapeutics to addiction sufferers in desperate need.

Awakn Life Sciences (Awakn Life Sciences) Headlines